January 5, 2024 Comments Off on New patent for Avadel Cns drug LUMRYZ Posted in: Patent Added Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent for Avadel Cns drug LUMRYZ appeared first on DrugPatentWatch…
January 5, 2024 Comments Off on New patent for Boehringer Ingelheim drug TRIJARDY XR Posted in: Patent Added Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent for Boehringer Ingelheim drug TRIJARDY XR appear…